These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28112249)

  • 1. Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC.
    Liu J; Xing Y; Xu L; Chen W; Cao W; Zhang C
    Sci Rep; 2017 Jan; 7():41179. PubMed ID: 28112249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis.
    Gong T; Zheng S; Huang S; Fu S; Zhang X; Pan S; Yang T; Sun Y; Wang Y; Hui B; Guo J; Zhang X
    Mol Carcinog; 2017 Dec; 56(12):2610-2619. PubMed ID: 28731203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma.
    Gao L; Ren W; Zhang L; Li S; Kong X; Zhang H; Dong J; Cai G; Jin C; Zheng D; Zhi K
    Mol Carcinog; 2017 Apr; 56(4):1322-1334. PubMed ID: 27862321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
    Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
    Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN.
    Guo X; Deng L; Deng K; Wang H; Shan T; Zhou H; Liang Z; Xia J; Li C
    Anticancer Agents Med Chem; 2016; 16(4):456-64. PubMed ID: 25968876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty2 protein is downregulated in human squamous cell carcinoma of the head and neck and suppresses cell proliferation in vitro.
    Lin CL; Chiang WF; Tung CL; Hsieh JL; Hsiao JR; Huang WT; Feng LY; Chang CH; Liu SY; Tsao CJ; Feng YH
    Mol Med Rep; 2015 Jan; 11(1):547-54. PubMed ID: 25333206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Activity of the Pseudogene
    Yndestad S; Austreid E; Skaftnesmo KO; Lønning PE; Eikesdal HP
    Mol Cancer Res; 2018 Jan; 16(1):78-89. PubMed ID: 29021233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
    Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on expression of PTEN gene and its pseudogene PTENP1 in acute leukemia and correlation between them].
    Wang CC; Huai L; Zhang CP; Jia YJ; Li QH; Chen YR; Tian Z; Tang KJ; Xing HY; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):896-901. PubMed ID: 23363743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.
    Yu G; Yao W; Gumireddy K; Li A; Wang J; Xiao W; Chen K; Xiao H; Li H; Tang K; Ye Z; Huang Q; Xu H
    Mol Cancer Ther; 2014 Dec; 13(12):3086-97. PubMed ID: 25249556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.
    Burgucu D; Guney K; Sahinturk D; Ozbudak IH; Ozel D; Ozbilim G; Yavuzer U
    BMC Cancer; 2012 Oct; 12():481. PubMed ID: 23082988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?
    Ioffe YJ; Chiappinelli KB; Mutch DG; Zighelboim I; Goodfellow PJ
    Gynecol Oncol; 2012 Feb; 124(2):340-6. PubMed ID: 22005521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
    Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
    J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.